Witness Credibility Analysis
AI in Employment: States Tighten Regulations to Help Curb Algorithmic Discrimination
Artificial intelligence (AI) continues to reshape how we live everyday life, influencing how we communicate, work, and even make routin...
New Class Action Targets Healthcare AI Recordings: 6 Steps All Businesses Should Consider to Limit Exposure
A newly filed class action in San Diego highlights a key risk for any business deploying AI tools that listen, record, or summarize cus...
[Webinar] ADA Compliance Obligations for Businesses: Minimizing Legal Risks and Reputational Damage – December 11th, 10:00 am PT
Regardless of whether you own or manage a hotel, store, restaurant, hospital, or any other place of business frequented by members of t...
[Webinar] 2026 IP Outlook on Patents, Trademarks, Copyrights, and Trade Secrets – December 16th, 12:00 pm – 1:00 pm EST
The intellectual property (IP) landscape continues to evolve rapidly, with significant developments impacting patent, trademark, copyri...
USPTO Suggests Use of Rule 132 Declarations and Updated Examiner Guidelines to Address Patent Subject Matter Eligibility Issues
In follow up to the August 4, 2025 guidance and September 26, 2025 In re Desjardins decision, the USPTO recently took another significa...
CFTC Announces Launch of First Leveraged Spot Cryptocurrency Listed on a CFTC-Regulated Exchange
On December 4, 2025, the Commodity Futures Trading Commission (CFTC) announced the upcoming launch of the first leveraged spot cryptocu...
Persuading Judges to Like You and Trust You: eDiscovery Webinars
What a terrific topic! Lexbe has a webinar this Friday discussing techniques for persuading judges to like you and trust you!
The post ...
New York Enacts 2022 UCC Amendments, Including Article 12 and Related Article 9 Revisions
Governor Hochul of New York signed Assembly Bill 3307-A/Senate Bill 1840-A into law, enacting 2022 Uniform Commercial Code amendments, ...
Hottest Patent Term of 2026? SMED.
Every year has its “it” term.In 2025, the crown belonged to AI, and rightfully so. AI dominated the headlines, flooded the USPTO’s dock...
The Cost of Free: What Removing FDA User Fees Could Mean for Drug Innovation and Public Health
In the ongoing debate over regulatory reform, the MAHA Commission’s proposal to eliminate FDA user fees has sparked renewed scrutiny of...